Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients

NCT02375633 is registered in ClinicalTrials.gov with Daewon Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02375633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02375633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients
Lead sponsor
Daewon Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2014
Completion date
Not reported
Enrollment
166 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic back pain